Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDivestmentsFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Capital Expenditures (2020 - 2026)

Cresco Labs filings provide 7 years of Capital Expenditures readings, the most recent being -$7.6 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 31.28% to -$7.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$1.7 million, a 72.02% increase, with the full-year FY2025 number at $97000.0, down 80.2% from a year prior.
  • Capital Expenditures hit -$7.6 million in Q1 2026 for Cresco Labs, down from $26.2 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $152.9 million in Q4 2022 to a low of -$39.8 million in Q2 2023.
  • Median Capital Expenditures over the past 5 years was -$7.2 million (2025), compared with a mean of $7.7 million.
  • Biggest five-year swings in Capital Expenditures: surged 104.65% in 2023 and later crashed 800.96% in 2025.
  • Cresco Labs' Capital Expenditures stood at $152.9 million in 2022, then tumbled by 30.71% to $106.0 million in 2023, then plummeted by 84.16% to $16.8 million in 2024, then surged by 56.27% to $26.2 million in 2025, then crashed by 129.13% to -$7.6 million in 2026.
  • The last three reported values for Capital Expenditures were -$7.6 million (Q1 2026), $26.2 million (Q4 2025), and -$7.2 million (Q3 2025) per Business Quant data.